23andMe cuts 40% of staff in restructuring

23andMe announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at the company. The genetic testing company is also

discontinuing its therapeutics business and winding down its clinical trials; it expects these changes to save $35 million annually.

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer business and research partnerships,” said CEO and

co-founder Anne Wojcicki in a press release. “I want to thank our team for their hard work and dedication to our mission.”

On Tuesday, 23andMe reported $44 million in revenue during the second quarter, a decline from $50 million during the same period last year.

The mass workforce reductions mark the latest disruption in a tumultuous year for 23andMe. In September, 23andMe’s entire board of directors — including Silicon Valley icons such as YouTube

CEO Neal Mohan — resigned following Wojcicki’s attempt to take the company private in August.

To start 2024 off, 23andMe was trying to save its reputation after a massive cyberattack, in which hackers stole ancestry data on 6.9 million users.

On a personal level, this has also been a difficult year for Anne Wojcicki, whose sister died in August. Susan Wojcicki was the longtime CEO of YouTube, and many people in Silicon Valley saw

her as a visionary.

On Tuesday, 23andMe’s stock was slightly up, ending the day at $4.71 a share, but still significantly down from its 2021 high, which at one point reached over $300.

Techcrunch eventSave $200+ on your TechCrunch All Stage passBuild smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and

beyond for a day packed with strategies, workshops, and meaningful connections.Save $200+ on your TechCrunch All Stage passBuild smarter. Scale faster. Connect deeper. Join visionaries from

Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections.Boston, MA|July 15REGISTER NOW Topics

Biotech & Health, tech layoffsMaxwell Zeff

Senior AI Reporter

Maxwell Zeff is a senior reporter at TechCrunch specializing in AI. Previously with Gizmodo, Bloomberg, and MSNBC, Zeff has covered the rise of AI and the Silicon Valley Bank crisis. He is

based in San Francisco. When not reporting, he can be found hiking, biking, and exploring the Bay Area’s food scene.View Bio July 15, 2025Boston, MA From seed to Series C and beyond—founders

and VCs of all stages are heading to Boston. Be part of the conversation. Save $200+ now and tap into powerful takeaways, peer insights, and game-changing connections.

Popular

Google Cloud outage brings down a lot of the internet

Europe, we’re not leaving. Period.

OpenAI releases o3-pro, a souped-up version of its o3 AI reasoning model

WWDC 2025: Everything announced, including Liquid Glass, Apple Intelligence updates, and more

Major US grocery distributor warns of disruption after cyberattack

Anthropic’s AI-generated blog dies an early death

Superblocks CEO: How to find a unicorn idea by studying AI system prompts

Julie Bort